You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
恆指升幅擴至逾200點再探頂 中海油/藥明生物/科技股領漲 惟蒙牛及創科跌逾3%-5%
阿思達克 01-14 15:32
內地去年12月貿易數據勝預期。港股扭轉昨天反覆回軟勢,今天在重磅科技股帶動高開173點或0.6%報28,408後,早段曾回順至28,280拒絕再下,午後升幅擴大至227點或0.8%,報28,463,成交額1,795億元。

外電引述消息人士指,美國政府決定不把騰訊(00700.HK)及阿里巴巴(09988.HK)等中國科技巨企納入禁止投資制裁名單,兩者股價漲半成分別報626.5元及235元。美團(03690.HK)升5.9%報313.8元。

受惠北水垂青中海油(00883.HK)續漲逾6%高見8.35元;聯通(00762.HK)及中移動(00941.HK)升逾2.5%,分別高見5.13元及48.1元。藥明生物(02269.HK)再度逼近紀錄高位104.8元,最高見104.5元,現造104.2元,續升5.6%。

相反,創科(00669.HK)吐5.3%報112.5元;蒙牛(02319.HK)續跌逾3%報47.9元。兩大濠賭股金沙(01928.HK)及銀娛(00027.HK)也跌2%-3%,分別低見31.05元及58.05元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account